References
- Wang Z Y, Chen Z. Acute promyelocytic leukemia: from highly fatal to highly curable. Blood 2008; 111: 2505–2515
- Douer D. The epidemiology of acute promyelocitic leukemia. Best Pract Res Clin Haematol 2003; 16: 357–367
- Kelly L M, Kutok J L, Willians I R, Boulton C L, Amaral S M, Curley D P, et al. PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model. Proc Natl Acad Sci USA 2002; 99: 8283–8288
- Gilliland D G. FLT3-activating mutations in acute promyelocytic leukemia: a rationale for risk-adapted therapy with FLT3 inhibitors. Best Pract Res clin Haematol 2003; 16: 409–417
- Yamamoto Y, Kiyoi H, Nakano Y, Suzuki R, Kodera Y, Miyawaki S, et al. Activating mutation of D835Y within the activation loop of FLT3 in human hematologic malignancies. Blood 2001; 97: 2434–2439
- Roldán T MM, Ramirez P H, Guerchicoff E S, Antuña G M, Santovenia J MB. Frecuencia de la leucemia promielocítica em Cuba. Rev Cubana Hematol Inmunol Hemoter 2001; 17: 49–54
- Jaffe E S, Harris N L, Stein H, Vardiman J W. World Health Organization Classification of Tumors. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon 2001
- Chauffaille M L, Figueiredo M S, Beltrani R, Antunes S V, Yamamoto M, Kerbauy J. Acute promyelocytic leukemia: the study of t(15;17) translocation by fluorescent in situ hybridization, reverse transcriptase-polymerase chain reaction and cytogenetic techniques. Braz J Med Biol Res 2001; 34: 735–743
- ISCN. An International System for Human Cytogenetic Nomenclature. L G Shaffer, N Tommerup. S. Karger, Basel 2005
- Nakao M, Yokota S, Iwai T, Kaneko H, Horiike S, Kashima K, et al. Internal tandem duplication of the flt3 gene found in acute myeloid leukemia. Leukemia 1996; 10: 1911–1918
- Botton S, Chevret S, Sanz M, Dombret H, Thomaz X, Guerci A, et al. Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 96 trial. Br J Haematol 2000; 111: 801–806
- Ribeiro R C, Rego E. Management of APL in developing countries: epidemiology, challenges abd opportunities for International Collaboration, Hematology. American Society of Hematology Education Book; Washington DC; 2006. 162–168
- Xu L, Zhao W L, Su X Y, Zhao M, Wang C, Gao Y R, et al. Molecular cytogenetic characterization and clinical relevance of addition, complex and/variant chromosome abnormalities in acute promyelocytic leukemia. Leukemia 2001; 15: 1359–1368
- Thiede C, Steudel C, Mohr B, Schaich M, Schakel U, Platzbecker U, et al. Analysis of FLT3-activating mutations in 979 patients with acute myelogenoos leukemia: association with FAB subtypes, and identification of subgroups with poor prognosis. Blood 2002; 99: 4326–4335
- Lo-Coco F, Ammatuna E. The biology of acute promyelocytic leukemia and its impact on diagnosis and treatment. Am Soc Hematol Washington DC 2006; 514: 156–161